In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. This is done using simple text files called cookies which sit on your computer. By continuing to use this site and access its features, you are consenting to our use of cookies. To find out more about the way Informa uses cookies please go to our Cookie Policy page.

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

INTERVIEW: ViroMed Seeks Partnerships With Active Role

News

Executive Summary

South Korea’s ViroMed, a front runner in gene therapy involving naked plasmid DNA, is searching for global partners for its leading project VM202 but is apparently in no hurry to make a decision. In an exclusive interview, its founder and chief science officer tells PharmAsia News what sort of partnerships it is seeking and the goals it hopes to achieve in the coming years.